ANDREW S BOYER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDREW S BOYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDREW S BOYER. ANDREW S BOYER is SVP, Generic Sales & Marketing in Actavis, Inc. ($ACT) and SVP,Sales&Mktg,US Generics in Actavis, Inc. ($ACT) and VP, Sales & Marketing in Actavis, Inc. ($ACT) and Exec VP, Comm Optns in Amneal Pharmaceuticals, Inc. ($AMRX) and Executive Vice President in Amneal Pharmaceuticals, Inc. ($AMRX).
Latest Insider Trading Transactions of ANDREW S BOYER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 16,655 | 0 | 16,656 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 8,353 | 43,436 | 139,750 | 148.1 K to 139.8 K (-5.64 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 16,655 | 0 | 148,103 | 131.4 K to 148.1 K (+12.67 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 16,655 | 0 | 16,656 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 8,353 | 43,436 | 139,750 | 148.1 K to 139.8 K (-5.64 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 16,655 | 0 | 148,103 | 131.4 K to 148.1 K (+12.67 %) |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 250,966 | 0 | 250,966 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 125,483 | 0 | 125,483 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 12,346 | 0 | 24,692 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 31,662 | 0 | 94,987 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.18 | 6,192 | 32,075 | 131,448 | 137.6 K to 131.4 K (-4.50 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 12,346 | 0 | 137,640 | 125.3 K to 137.6 K (+9.85 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.39 | 16,301 | 87,862 | 125,294 | 141.6 K to 125.3 K (-11.51 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 31,662 | 0 | 141,595 | 109.9 K to 141.6 K (+28.80 %) |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 69,284 | 0 | 102,595 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 16,656 | 0 | 33,311 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 3.55 | 8,353 | 29,653 | 109,933 | 118.3 K to 109.9 K (-7.06 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 16,656 | 0 | 118,286 | 101.6 K to 118.3 K (+16.39 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 12,345 | 0 | 37,038 | |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 3.85 | 6,683 | 25,730 | 101,630 | 108.3 K to 101.6 K (-6.17 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 12,345 | 0 | 108,313 | 96 K to 108.3 K (+12.86 %) |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 253,298 | 0 | 253,298 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 126,649 | 0 | 126,649 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 2.75 | 100,553 | 276,521 | 100,553 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | D | 13.50 | 100,553 | 1,357,466 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 2.75 | 272,480 | 749,320 | 272,480 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | D | 15.01 | 272,480 | 4,089,925 | 0 | |
Aug 07 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | P | 2.89 | 66,666 | 192,665 | 95,968 | 29.3 K to 96 K (+227.51 %) |
May 13 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | P | 9.46 | 19,000 | 179,740 | 29,302 | 10.3 K to 29.3 K (+184.43 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 16,655 | 0 | 49,967 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 13.44 | 8,353 | 112,264 | 10,302 | 18.7 K to 10.3 K (-44.78 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 16,655 | 0 | 18,655 | 2 K to 18.7 K (+832.75 %) |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 66,622 | 0 | 66,622 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 15.01 | 272,480 | 4,089,925 | 272,480 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Mar 16 2010 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 41.37 | 1,654 | 68,426 | 38,913 | 40.6 K to 38.9 K (-4.08 %) |
Feb 26 2010 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Grant | A | 0.00 | 10,015 | 0 | 40,567 | 30.6 K to 40.6 K (+32.78 %) |
Aug 13 2009 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 34.63 | 270 | 9,350 | 30,552 | 30.8 K to 30.6 K (-0.88 %) |
Mar 13 2009 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 27.34 | 843 | 23,048 | 30,822 | 31.7 K to 30.8 K (-2.66 %) |
Mar 06 2009 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Grant | A | 0.00 | 9,980 | 0 | 31,665 | 21.7 K to 31.7 K (+46.02 %) |
Sep 03 2008 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 30.31 | 946 | 28,673 | 21,685 | 22.6 K to 21.7 K (-4.18 %) |
Mar 14 2008 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Grant | A | 0.00 | 10,200 | 0 | 22,631 | 12.4 K to 22.6 K (+82.05 %) |
Aug 14 2007 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 31.12 | 270 | 8,402 | 12,431 | 12.7 K to 12.4 K (-2.13 %) |
Jun 27 2007 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Grant | A | 0.00 | 5,200 | 0 | 12,701 | 7.5 K to 12.7 K (+69.32 %) |
Sep 05 2006 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP, Generic Sales ... | Option Exercise | A | 25.64 | 17,500 | 448,700 | 17,500 | |
Sep 05 2006 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP, Generic Sales ... | Grant | A | 0.00 | 5,834 | 0 | 7,501 | 1.7 K to 7.5 K (+349.97 %) |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 26.14 | 3,200 | 83,648 | 8,008 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 24.15 | 9,000 | 217,350 | 5,139 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 26.40 | 8,995 | 237,468 | 3,000 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 26.40 | 5 | 132 | 3,000 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 28.15 | 9,998 | 281,444 | 0 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | M | 28.15 | 2 | 56 | 0 | |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Sell | S | 35.60 | 31,200 | 1,110,720 | 1,667 | 32.9 K to 1.7 K (-94.93 %) |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Buy | M | 26.14 | 3,200 | 83,648 | 32,867 | 29.7 K to 32.9 K (+10.79 %) |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Buy | M | 24.15 | 9,000 | 217,350 | 29,667 | 20.7 K to 29.7 K (+43.55 %) |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Buy | M | 26.40 | 9,000 | 237,600 | 20,667 | 11.7 K to 20.7 K (+77.14 %) |
Aug 24 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Buy | M | 28.15 | 10,000 | 281,500 | 11,667 | 1.7 K to 11.7 K (+599.88 %) |
Aug 15 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | A | 35.11 | 4,725 | 165,895 | 4,725 | |
Aug 15 2005 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Grant | A | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
Aug 12 2004 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Sell | S | 27.97 | 825 | 23,078 | 0 | 825 to 0 (-100.00 %) |
Aug 12 2004 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Sell | S | 27.91 | 1,100 | 30,698 | 825 | 1.9 K to 825 (-57.14 %) |
Aug 11 2004 | ACT | Actavis, Inc. | BOYER ANDREW S | VP, Sales & Marketi ... | Option Exercise | A | 26.14 | 16,000 | 418,240 | 16,000 |
Page: 1